JAGSONPAL PHARMACEUTICALS
|
The Current P/S Ratio of JAGSONPAL PHARMACEUTICALS is 4.13.
| Share Price | ₹174.3 | Jan 19,2026 |
| Market Cap | ₹1,166.1 Cr | |
| Sales-TTM | ₹282.7 Cr | TTM-Standalone Results |
| Price/Sales | 4.13x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of JAGSONPAL PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,166.1 Cr] as on Jan 19,2026
(/) Sales [ ₹282.7 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 4.13x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay '4.13 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of JAGSONPAL PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of JAGSONPAL PHARMACEUTICALS
PS Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.40x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 3.55x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 5.34x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 1.11x.
How does JAGSONPAL PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| JAGSONPAL PHARMACEUTICALS | 282.7 | 4.13 | 1,166.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.31 | 401,541.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.26 | 163,031.0 |
| CIPLA LTD | 28,349.6 | 3.96 | 112,377.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.30 | 138,451.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.84 | 97,355.5 |
| MANKIND PHARMA LTD | 13,576.9 | 6.44 | 87,425.9 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.62 | 88,659.3 |
| LUPIN LTD | 24,750.7 | 4.02 | 99,499.9 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.08 | 67,791.2 |
| ABBOTT INDIA LTD | 6,714.4 | 8.79 | 59,016.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JAGSONPAL PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.08x |
| Max industry PS | 16.26x |
| Median industry PS | 4.13x |
| Average industry PS | 6.43x |
You may also like the below Video Courses